What’s fuelling the global neurological devices market?

The sector is witnessing substantial growth amidst advanced technology integration.

An increasing demand for advanced diagnostic and treatment technologies is driving the global neurological devices market to reach $20.9b by 2033 at a compound annual growth rate of 4.60%.

According to GlobalData’s Medical Devices Analyst, Cynthia Stinchcombe, the sector is seeing substantial growth amidst the integration of advanced technologies, fitting into a broader industry shift.

“The shift towards precision medicine is evident, especially with the FDA’s push for innovative Parkinson’s disease management solutions,” Stinchcombe said.

UC San Francisco studies from 2023 and 2024 show that adaptive deep brain stimulation (aDBS), a self-adjusting brain implant, improves movement and sleep for Parkinson’s patients, with trials showing reduced symptoms by 50%.

In addition to aDBS, other digital health developments are emerging in Parkinson’s care. Wearable technologies, such as those using Apple Watch data, are enabling continuous symptom monitoring outside clinical settings. 

“As the industry continues to focus on both proven and novel solutions, emerging technologies are pivotal in broadening the horizons of neurology diagnostics and improving patient outcomes,” Stinchcombe added.